| # | Drug | Count |
|---|---|---|
| 0 | LOPERAMIDE HYDROCHLORIDE | 4 |
| 1 | TEDUGLUTIDE | 3 |
| 2 | ACETAMINOPHEN | 2 |
| 3 | ACETAMINOPHEN 500MG | 2 |
| 4 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 2 |
| 5 | ASPIRIN | 2 |
| 6 | ASPIRIN 325 MG | 2 |
| 7 | ASPIRIN 81 MG | 2 |
| 8 | ATORVASTATIN CALCIUM | 2 |
| 9 | CALCIUM | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TALIMOGENE LAHERPAREPVEC | 1 | 0.0006 |
| 1 | PENTOXIFYLLINE | 1 | 0.0002 |
| 2 | TEDUGLUTIDE | 3 | 0.0002 |
| 3 | FLUOCINONIDE TOPICAL SOLUTION USP, 0.05% | 1 | 0.0002 |
| 4 | DASPONE | 1 | 0.0001 |
| 5 | DAPSONE GEL, 5% | 1 | 0.0001 |
| 6 | DAPSONE | 1 | 0.0001 |
| 7 | LOPERAMIDE HYDROCHLORIDE | 4 | 0.0001 |
| 8 | STANDARDIZED SENNA CONCENTRATE | 1 | 0.0001 |
| 9 | MAGNESIUM HYDROXIDE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 6 |
| 1 | GLP-2 Analog [EPC] | 3 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 3 |
| 3 | Vitamin B12 [EPC] | 3 |
| 4 | Atypical Antipsychotic [EPC] | 2 |
| 5 | Calcium [EPC] | 2 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 2 |
| 7 | Platinum-based Drug [EPC] | 2 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 |
| 9 | Vitamin C [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 1 | GLP-2 Analog [EPC] | 3 | 0.0002 |
| 2 | Sulfone [EPC] | 1 | 0.0001 |
| 3 | Progesterone [EPC] | 1 | 0.0000 |
| 4 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 5 | Thiazide-like Diuretic [EPC] | 1 | 0.0000 |
| 6 | Pyrimidine Synthesis Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 | 0.0000 |
| 8 | Calcium [EPC] | 2 | 0.0000 |
| 9 | Arteriolar Vasodilator [EPC] | 1 | 0.0000 |